Sexual health services in the UK will start rolling out a 'world-first' vaccine programme designed to protect people from ...

The world’s first gonorrhoea vaccination programme will be rolled out on the NHS. Cases of the sexual disease in England ...

England will be the first country to offer a gonorrhoea vaccine to high-risk groups, as cases hit record highs and resistance ...

The initiative has been described as a "significant breakthrough for public health" and will use an existing vaccine, 4CMenB, ...

GSK is currently the market leader in the meningococcal vaccine market, racking up sales of £1.26 billion (almost $1.6 billion) last year across the Bexsero and Menveo brands, but is having to ...

Pentavalent vaccines can reduce the number of injections required to help protect against invasive meningococcal disease ... Important Safety Information for BEXSERO in the US The following ...

Importantly, Penmenvy integrates the antigenic components of GSK’s two widely used meningococcal vaccines, Bexsero (Meningococcal Group B Vaccine) and Menveo (Meningococcal [Groups A ...

The Bexsero market report offers a comprehensive ... increased demand for meningococcal vaccines, robust healthcare infrastructure, and enhanced disease awareness. In the forecast period, growth ...

The outcome of a trial published in Science Translational Medicine, shows encouraging results for a new vaccine targeting ...

About PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine) GSK’s MenABCWY vaccine ... Important Safety Information for BEXSERO in the US The following is based on the US Prescribing ...